Insider trades

Hans-Peter Gerber, Chief Officer of Sutro Biopharma STRO, has filed 1 purchase and 0 sales on the open market. Over the past 12 months that comes to a net purchase of $13.6K. The latest trade was on 03/02.

Hans-Peter Gerber

Chief Scientific Officer
First filing
23/09/19
Trades
25 trades
Buys / sales
1 / 0
12-month net buying
$13.6K
Last trade
03/02

Trading activity

Transactions

Trade type
Open-market buy25/10/1525/10/1617,000 sh$0.80$13,600+31.0%